Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Agathe Vély, Marie-Anne Couturier, Pascal Delepine, Ronan Le Calloch, Marjan Ertault, Thomas Gastinne, Chloé Plichon, Anne Lebreton, Marie-Antoinette Lester, Gaelle Larhantec, Nicolas Cormier, Sophie Fouquet, Roch Houot, Aline Tanguy-Schmidt, Mathilde Hunault-Berger & Corentin Orvain. (2023) Comparison of efficacy and toxicity according to etoposide and cytarabine dosing in BEAM conditioning followed by autologous stem cell transplantation in Hodgkin lymphoma. Leukemia & Lymphoma 0:0, pages 1-10.
Read now
Read now
Adrienne A. Phillips & Koen van Besien. (2015) A new “age” for high dose therapy and autologous stem cell transplant. Leukemia & Lymphoma 56:8, pages 2233-2234.
Read now
Read now
Articles from other publishers (15)
Agathe Vely, Jérôme Paillassa, Christopher Nunes Gomes, Aurélien Giltat, Sophie Fouquet, Anne Lebreton, Marion Klemencie, Aline Clavert, Aline Tanguy-Schmidt, Mathilde Hunault-Berger & Corentin Orvain. (2023) Toxicity Profile According to Etoposide and Cytarabine Dosing in Patients with Lymphoma Receiving Autologous Stem Cell Transplantation Following BEAM Conditioning. Annals of Hematology 102:8, pages 2225-2231.
Crossref
Crossref
Shunsuke Yui, Satoshi Wakita, Yasunobu Nagata, Yasuko Kuribayashi, Toshio Asayama, Yusuke Fujiwara, Masahiro Sakaguchi, Satoshi Yamanaka, Atsushi Marumo, Ikuko Omori, Ryosuke Kinoshita, Daishi Onai, Mika Sunakawa, Yuta Kaito, Kazuki Inai, Taichiro Tokura, Atsushi Takeyoshi, Shunichi Yasuda, Shunsuke Honma, Kazutaka Nakayama, Tsuneaki Hirakawa, Kunihito Arai, Tomoaki Kitano, Muneo Okamoto, Koiti Inokuchi & Hiroki Yamaguchi. (2022) Safety and efficacy of high‐dose cytarabine MEAM therapy and other treatments for auto‐peripheral blood stem cell transplantation: A retrospective comparative study. Asia-Pacific Journal of Clinical Oncology 19:1, pages 136-148.
Crossref
Crossref
Sanjeev Kumar SharmaSanjeev Kumar Sharma. 2023. Basics of Hematopoietic Stem Cell Transplant. Basics of Hematopoietic Stem Cell Transplant
259
282
.
Mattias Carlsten, Martin Jädersten, Anna Hellström, Karin Littmann, Christopher M. Melén, Henna Riikka Junlén, Kristina Sonnevi, Per Ljungman, Bo Björkstrand & Björn Engelbrekt Wahlin. (2019) The Karolinska experience of autologous stem-cell transplantation for lymphoma: a population-based study of all 433 patients 1994–2016. Experimental Hematology & Oncology 8:1.
Crossref
Crossref
J. Tay, A. Daly, K. Jamani, L. Labelle, L. Savoie, D. Stewart, J. Storek & S. Beattie. (2018) Patient eligibility for hematopoietic stem cell transplantation: a review of patient-associated variables. Bone Marrow Transplantation 54:3, pages 368-382.
Crossref
Crossref
P Galieni, E Troiani, C Bigazzi, S Mazzotta, M Ruggieri, V Pezzoni, A Dalsass, F Mestichelli, P Caraffa, F Travaglini, S Ferretti, M Angelini, S Angelini & S Falcioni. (2017) Modified BEAM as conditioning regimen for lymphoma patients undergoing autologous hematopoietic stem cell transplantation. Bone Marrow Transplantation 53:1, pages 91-93.
Crossref
Crossref
K. Davison, B.E. Chen, V. Kukreti, S. Couban, A. Benger, N.L. Berinstein, L. Kaizer, P. Desjardins, J. Mangel, L. Zhu, M.S. Djurfeldt, A.E. Hay, L.E. Shepherd & M. Crump. (2017) Treatment outcomes for older patients with relapsed/refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: a subgroup analysis from the phase III CCTG LY.12 trial. Annals of Oncology 28:3, pages 622-627.
Crossref
Crossref
David Rizzieri. (2016) Zevalin® (ibritumomab tiuxetan): After more than a decade of treatment experience, what have we learned?. Critical Reviews in Oncology/Hematology 105, pages 5-17.
Crossref
Crossref
Veronika Bachanova & Joseph M. Connors. (2016) Hodgkin lymphoma in the elderly, pregnant, and HIV-infected. Seminars in Hematology 53:3, pages 203-208.
Crossref
Crossref
J M Schuurhuis, L F R Span, M A Stokman, A J van Winkelhoff, A Vissink & F K L Spijkervet. (2016) Effect of leaving chronic oral foci untreated on infectious complications during intensive chemotherapy. British Journal of Cancer 114:9, pages 972-978.
Crossref
Crossref
Magalie P. Tardy, Lauris Gastaud, Mario Ojeda-Uribe, Annick Boscagli, Salvatore Caruso, Richard Skaf, Jean Gutnecht, Antoine Thyss & Frédéric Peyrade. (2015) Z-BeEAM (Ibritumomab tiuxetan, Bendamustine, Etoposide, Cytarabine, Melphalan) before autologous stem cell transplantation is safe and efficient for refractory large B-cell lymphoma. Experimental Hematology & Oncology 4:1.
Crossref
Crossref
Aniruddha Agarwal, Mohammad Ali Sadiq, William R. Rhoades, Loren S. Jack, Mostafa Hanout, Philip J. Bierman, William W. West & Quan Dong Nguyen. (2015) Combined systemic and ocular chemotherapy for anterior segment metastasis of systemic mantle cell lymphoma. Journal of Ophthalmic Inflammation and Infection 5:1.
Crossref
Crossref
Satyen H. Gohil, Kirit M. Ardeshna, Jonathan M. Lambert, Martin A. Pule, Sajir Mohamedbhai, Andres Virchis, Emma C. Morris, David C. Linch, Kirsty J. Thomson & Karl S. Peggs. (2015) Autologous stem cell transplantation outcomes in elderly patients with B cell Non-Hodgkin Lymphoma. British Journal of Haematology 171:2, pages 197-204.
Crossref
Crossref
Lara Valiño-Rivas, Ciro Baeza-Bermejillo, Laura Gonzalez-Lafuente, Ana Belen Sanz, Alberto Ortiz & Maria Dolores Sanchez-Niño. (2015) CD74 in Kidney Disease. Frontiers in Immunology 6.
Crossref
Crossref
Oscar B. Lahoud, Craig S. Sauter, Paul A. Hamlin & Parastoo Bahrami Dahi. (2015) High-Dose Chemotherapy and Autologous Stem Cell Transplant in Older Patients with Lymphoma. Current Oncology Reports 17:9.
Crossref
Crossref